CYLD was initially identified as a tumor suppressor and has recently been identified as an important ciliary regulator, as both CKO mice and transgenic mice carrying truncations in the carboxyl-terminal deubiquitinase domain of CYLD exhibit ciliary defects [13, 14]. Here, CYLD is linked to neoplasm.